We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Ralph Lauren
RL
$22.2B
| $396K | ﹤0.01% |
4,660
+45
| +1% | +$4.24K |
|
1577
Arcturus Therapeutics
ARCT
$160M
| $395K | ﹤0.01% |
26,680
-9,940
| -27% | -$167K |
|
|
EVBG
1578
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $395K | ﹤0.01% |
12,800
| – | – |
|
1579
Cohu
COHU
$1.86B
| $394K | ﹤0.01% |
15,280
| – | – |
|
1580
IPG Photonics
IPGP
$3.41B
| $394K | ﹤0.01% |
4,670
-188
| -4% | -$17.9K |
|
1581
Triumph Financial Inc
TFIN
$1.82B
| $394K | ﹤0.01% |
7,250
| – | – |
|
1582
Adtran
ADTN
$676M
| $393K | ﹤0.01% |
20,094
| – | – |
|
|
NXRT
1583
NexPoint Residential Trust
NXRT
$691M
| $393K | ﹤0.01% |
8,500
| – | – |
|
1584
Kyndryl
KD
$3.05B
| $391K | ﹤0.01% |
47,250
+8,620
| +22% | +$89.7K |
|
1585
StoneX
SNEX
$8.69B
| $390K | ﹤0.01% |
23,794
| – | – |
|
1586
FormFactor
FORM
$6.45B
| $388K | ﹤0.01% |
15,490
| – | – |
|
1587
TG Therapeutics
TGTX
$8.14B
| $388K | ﹤0.01% |
65,580
-49,850
| -43% | -$327K |
|
|
TE
1588
T1 Energy
TE
$1.03B
| $388K | ﹤0.01% |
27,280
-3,150
| -10% | -$35.2K |
|
|
KNBE
1589
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $387K | ﹤0.01% |
18,590
+7,520
| +68% | +$139K |
|
1590
Axsome Therapeutics
AXSM
$11.7B
| $386K | ﹤0.01% |
8,650
-2,670
| -24% | -$133K |
|
1591
Traeger
COOK
$166M
| $386K | ﹤0.01% |
2,741
-70
| -2% | -$11.8K |
|
1592
Howard Hughes
HHH
$4.01B
| $385K | ﹤0.01% |
+7,291
| New | +$466K |
|
1593
Sunstone Hotel Investors
SHO
$2.2B
| $385K | ﹤0.01% |
+40,870
| New | +$442K |
|
1594
Herc Holdings
HRI
$4.8B
| $383K | ﹤0.01% |
3,690
+1,420
| +63% | +$158K |
|
|
OSG
1595
Octave Specialty Group
OSG
$257M
| $381K | ﹤0.01% |
29,900
-10,000
| -25% | -$133K |
|
1596
Riot Platforms
RIOT
$7.28B
| $380K | ﹤0.01% |
54,230
-82,160
| -60% | -$578K |
|
1597
Stewart Information Services
STC
$2.14B
| $380K | ﹤0.01% |
8,700
| – | – |
|
1598
Vicor
VICR
$8.27B
| $380K | ﹤0.01% |
6,430
-320
| -5% | -$21.1K |
|
|
MODV
1599
DELISTED
ModivCare
MODV
| $378K | ﹤0.01% |
3,794
| – | – |
|
1600
Gibraltar Industries
ROCK
$1.3B
| $378K | ﹤0.01% |
9,247
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.